CareDx, Inc (CDNA)

CareDx Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	358	333.79	280.32	321.79	296.4	192.19
Revenue Growth (YoY)	14.46%	19.07%	-12.89%	8.57%	54.22%	51.25%
Cost of Revenue	115.85	109.63	102	112.21	97.39	63.12
Gross Profit	242.15	224.16	178.33	209.58	199.01	129.08
Selling, General & Admin	202.68	205.5	200.5	196.42	152.21	102.66
Research & Development	68.64	72.41	81.87	90.39	76.53	48.94
Operating Expenses	271.32	277.91	282.37	286.81	228.73	151.61
Operating Income	-29.17	-53.75	-104.04	-77.23	-29.73	-22.53
Interest & Investment Income	10.53	11.77	11.87	3.76	1.29	0.27
Other Non Operating Income (Expenses)	0.4	0.03	-0.15	-2.77	-0.78	-2.31
EBT Excluding Unusual Items	-18.24	-41.96	-92.32	-76.23	-29.22	-24.56
Merger & Restructuring Charges	-1.78	-1.78	-3.02	-	-	-
Gain (Loss) on Sale of Investments	-0.02	0.3	1.5	-	-2.87	-
Legal Settlements	90.59	96.3	-96.3	-	-	-
Other Unusual Items	-	-	-	-	-	4.81
Pretax Income	70.55	52.86	-190.14	-76.23	-32.09	-19.75
Income Tax Expense	0.1	0.31	0.14	0.38	-1.43	-1.04
Earnings From Continuing Operations	70.45	52.55	-190.28	-76.61	-30.66	-18.71
Net Income	70.45	52.55	-190.28	-76.61	-30.66	-18.71
Net Income to Common	70.45	52.55	-190.28	-76.61	-30.66	-18.71
Shares Outstanding (Basic)	54	53	54	53	52	46
Shares Outstanding (Diluted)	58	57	54	53	52	46
Shares Change (YoY)	10.25%	5.31%	0.83%	2.07%	12.39%	10.27%
EPS (Basic)	1.30	1.00	-3.54	-1.44	-0.59	-0.40
EPS (Diluted)	1.22	0.93	-3.54	-1.44	-0.59	-0.40
Free Cash Flow	37.09	31.56	-26.73	-46.47	-32.85	26.32
Free Cash Flow Per Share	0.64	0.56	-0.50	-0.87	-0.63	0.57
Gross Margin	67.64%	67.16%	63.61%	65.13%	67.14%	67.16%
Operating Margin	-8.15%	-16.10%	-37.11%	-24.00%	-10.03%	-11.72%
Profit Margin	19.68%	15.74%	-67.88%	-23.81%	-10.35%	-9.74%
Free Cash Flow Margin	10.36%	9.46%	-9.54%	-14.44%	-11.08%	13.69%
EBITDA	-14.67	-39.56	-89.66	-65.64	-20.93	-15.52
EBITDA Margin	-4.10%	-11.85%	-31.98%	-20.40%	-7.06%	-8.08%
D&A For EBITDA	14.5	14.19	14.39	11.6	8.8	7.01
EBIT	-29.17	-53.75	-104.04	-77.23	-29.73	-22.53
EBIT Margin	-8.15%	-16.10%	-37.11%	-24.00%	-10.03%	-11.72%
Effective Tax Rate	0.14%	0.59%	-	-	-	-
Revenue as Reported	358	333.79	280.32	321.79	296.4	192.19

Updated Nov 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q